Oil Surge & Iran War Rattle Markets; Cureety Buys Reimagine Care

Healthcare Practice & Business Deals

This week’s most notable qualifying transaction is an AI-driven oncology acquisition, while the broader healthcare M&A pipeline shows revenue-cycle consolidation continuing at pace.

Cureety Acquires Reimagine Care. Cureety has completed its acquisition of Reimagine Care, combining two companies focused on AI-driven precision oncology. Together, the platforms now support more than 250 cancer centers covering more than 100,000 patients across five countries, according to executives. Financial terms of the deal were not disclosed. The transaction positions the combined entity as a scaled remote-care and clinical-intelligence player within the oncology space — a segment drawing increasing attention from health systems and specialty practice investors alike.

Cushla and Clirinx Merge on Rare-Disease Data. Two Irish startups — Cushla and Clirinx — are merging with the stated goal of giving rare-disease patients a single, continuous health and research record, preventing data loss when patients transition between care settings or studies. Terms were not disclosed. Though small in scale, the deal reflects a growing interest among specialty-data companies in building longitudinal patient records as a defensible asset in the rare-disease and clinical-trial market.

RCM Sector Sees Continued Roll-Up Activity. A Becker’s roundup highlights twelve revenue-cycle management M&A moves announced or completed since mid-March. Named transactions include R1 RCM agreeing to acquire an AI-powered touchless prior-authorization company, IKS Health acquiring TruBridge, and a company identified as 27 acquiring ABW Medical, an ambulatory RCM firm serving the non-acute healthcare market. Financial terms across these deals were not individually disclosed in the source, but the volume underscores sustained private-equity and strategic interest in practice-adjacent technology and billing infrastructure.

Global Markets & Macro

Markets are navigating a volatile convergence of geopolitical conflict, central-bank hawkishness, and large corporate deal-making as the week opens.

US-Iran War Keeps Oil and Bond Yields Elevated. Stocks fell and bond yields remained elevated as intensifying US-Iran hostilities pushed oil prices higher, according to Bloomberg’s markets wrap. US diesel advanced to its highest price since April — when the initial phase of the US-Iran conflict sent energy prices sharply higher — underscoring inflationary pressures rippling through the global economy. The US 10-year yield touched its highest level since 2023, per the Financial Times, while European natural gas reached a three-year high. Apollo Global Management’s chief economist stated that Iran war dynamics and tariffs — rather than US fiscal policy — are the primary drivers pushing US yields higher, and noted that policy concerns in Japan and Germany are viewed as more acute than those in the United States.

Central Banks Signal Hawkish Pivot. The prospect of interest-rate hikes in September across major economies is now “firmly in play,” Bloomberg reported. Bank of Japan board member Hajime Takata, described as one of the BOJ’s most hawkish members, left the door open for an outsized rate increase as well as back-to-back hikes, sending the yen strengthening against the dollar. Separately, Nomura International said the possibility of back-to-back European Central Bank rate hikes could lift the euro toward its year-end target of $1.20.

Nvidia Nears $14 Billion Deal to Acquire Hugging Face. Nvidia is nearing a $14 billion deal to acquire Hugging Face, according to Bloomberg. The potential transaction — one of the largest in the AI sector — would give the dominant chip designer direct ownership of one of the most widely used platforms for open-source AI models and developer tools, deepening its vertical integration across the AI stack at a moment when commentary around AI valuations and concentration risk is intensifying.

Chevron Commits $7 Billion to Venezuela. Chevron plans to more than double its oil production in Venezuela, committing $7 billion over the next five years in what Bloomberg and the Financial Times describe as the company’s largest financial commitment in the country. The investment comes as part of a White House-led push to revive Venezuelan oil output, adding a significant new supply variable to an energy market already strained by Middle East conflict.

Pentagon Turmoil Deepens Amid Iran War. Army Secretary Dan Driscoll resigned following clashes with Defense Secretary Pete Hegseth over Army leadership and modernization, leaving the service without Senate-confirmed civilian or uniformed leadership during an active conflict, according to Axios and the Financial Times. Hegseth has overseen the departure of more than two dozen senior officers, including the Joint Chiefs chairman, the Navy’s top admiral, and the Army chief of staff. Axios reported that the Navy’s top admiral warned that barely one-quarter of its destroyers are ready to deploy, and that the war has consumed 65% of the US Patriot interceptor inventory.

What to Watch

The coming days will test whether equity markets can stabilize if oil and bond yields remain at elevated levels, or whether central-bank hawkishness from Tokyo to Frankfurt accelerates a broader risk-off move. For healthcare practice owners and buyers, rising borrowing costs make deal financing more expensive, putting a premium on cash-flow-positive practices and tightening valuation multiples in leveraged roll-ups — particularly in the RCM and specialty-care segments where deal activity remains brisk. The Nvidia–Hugging Face deal, if confirmed, will set a new benchmark for AI asset valuations and could accelerate technology spending across health systems already racing to integrate AI into clinical and administrative workflows.

Editorial note, image use & corrections. This report is compiled and summarized from publicly available news sources; figures and details should be independently verified. Accompanying images are used under Creative Commons or public-domain licenses (sourced via Openverse) and credited where required. If you believe any content — written or image — has been used in error, is inaccurate, or infringes your rights, or you wish to request a correction or removal, please contact us at info@tenetma.com and we will address it promptly.